# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-067199
Filing Date
2023-08-14
Accepted
2023-08-14 17:00:55
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0623_actiniumphar.htm iXBRL | 10-Q | 805000
2 | CERTIFICATION | f10q0623ex31-1_actiniumphar.htm | EX-31.1 | 7748
3 | CERTIFICATION | f10q0623ex31-2_actiniumphar.htm | EX-31.2 | 7810
4 | CERTIFICATION | f10q0623ex32-1_actiniumphar.htm | EX-32.1 | 3759
5 | CERTIFICATION | f10q0623ex32-2_actiniumphar.htm | EX-32.2 | 3737
11 | GRAPHIC | image_001.jpg | GRAPHIC | 27849
12 | GRAPHIC | image_002.jpg | GRAPHIC | 27179
13 | GRAPHIC | image_003.jpg | GRAPHIC | 32141
14 | GRAPHIC | image_004.jpg | GRAPHIC | 28425
15 | GRAPHIC | image_005.jpg | GRAPHIC | 18718
16 | GRAPHIC | image_006.jpg | GRAPHIC | 26113
17 | GRAPHIC | image_007.jpg | GRAPHIC | 24924
18 | GRAPHIC | image_008.jpg | GRAPHIC | 16821
19 | GRAPHIC | image_009.jpg | GRAPHIC | 25398
20 | GRAPHIC | image_010.jpg | GRAPHIC | 15246
21 | GRAPHIC | image_011.jpg | GRAPHIC | 21593
22 | GRAPHIC | image_012.jpg | GRAPHIC | 28374
23 | GRAPHIC | image_013.jpg | GRAPHIC | 36999
| Complete submission text file | 0001213900-23-067199.txt |  | 4262968

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | atnm-20230630.xsd | EX-101.SCH | 36714
7 | XBRL CALCULATION FILE | atnm-20230630_cal.xml | EX-101.CAL | 22214
8 | XBRL DEFINITION FILE | atnm-20230630_def.xml | EX-101.DEF | 151124
9 | XBRL LABEL FILE | atnm-20230630_lab.xml | EX-101.LAB | 341918
10 | XBRL PRESENTATION FILE | atnm-20230630_pre.xml | EX-101.PRE | 165595
54 | EXTRACTED XBRL INSTANCE DOCUMENT | f10q0623_actiniumphar_htm.xml | XML | 268600

Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 231171735
SIC: 2834 Pharmaceutical Preparations